Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For FRPT
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 3.69 4.97 4.79
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 49.99 6.78 4.52
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.40 20.24 19.76
Cash -13.27 5.34 6.15
Capex 40.09 -0.96 -1.61
Free Cash Flow -1.29 -0.85 -0.84
Revenue 3.75 4.63 4.47
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 19.08 0.39 0.33
Operating Margin -44.80 0.04 0.07
ROA 20.33 0.01 0.01
ROE 18.63 0.02 0.02
ROIC -46.99 < 0.005 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of FRPT is permitted for members.
5 Growth
The "Growth Entry" for the Focus of FRPT is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of FRPT is permitted for members.